Raymond James & Associates’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,996
| Closed | -$692K | – | 3995 |
|
|
2021
Q1 | $692K | Buy |
7,996
+348
| +5% | +$30.1K | ﹤0.01% | 2761 |
|
|
2020
Q4 | $645K | Sell |
7,648
-716
| -9% | -$60.4K | ﹤0.01% | 2627 |
|
|
2020
Q3 | $668K | Sell |
8,364
-8,392
| -50% | -$670K | ﹤0.01% | 2428 |
|
|
2020
Q2 | $1.49M | Buy |
16,756
+463
| +3% | +$41K | ﹤0.01% | 1898 |
|
|
2020
Q1 | $1.53M | Sell |
16,293
-942
| -5% | -$88.6K | ﹤0.01% | 1727 |
|
|
2019
Q4 | $1.86M | Sell |
17,235
-435
| -2% | -$46.9K | ﹤0.01% | 1870 |
|
|
2019
Q3 | $1.69M | Sell |
17,670
-65
| -0.4% | -$6.23K | ﹤0.01% | 1875 |
|
|
2019
Q2 | $1.7M | Buy |
17,735
+756
| +4% | +$72.3K | ﹤0.01% | 1891 |
|
|
2019
Q1 | $1.5M | Buy |
16,979
+1,542
| +10% | +$136K | ﹤0.01% | 1952 |
|
|
2018
Q4 | $1.28M | Sell |
15,437
-612
| -4% | -$50.9K | ﹤0.01% | 1938 |
|
|
2018
Q3 | $1.51M | Buy |
16,049
+5,945
| +59% | +$560K | ﹤0.01% | 1985 |
|
|
2018
Q2 | $1.11M | Buy |
10,104
+1,508
| +18% | +$166K | ﹤0.01% | 2127 |
|
|
2018
Q1 | $850K | Buy |
+8,596
| New | +$850K | ﹤0.01% | 2250 |
|